arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

download Export Data

Indaptus Therapeutics, Inc.

INDP

$1.20 ▼ -0.03 (-2.85%) at close

26 Visible periods

19 Metrics

Absolute Benchmarks

Price Chart

Health

Weak

Bearish Absolute basis

auto_awesome

Analytical Summary

On an absolute basis, Indaptus Therapeutics, Inc. shows weak fundamentals, weighed down by Return on Invested Capital and FCF / Net Income. These readings use fixed quality thresholds rather than peer benchmarks, because too few comparable companies are available to rank against.

Market Cap $13.1M

Dividend Yield —

Revenue Growth —

Op. Margin —

ROIC -136.7% ↗

FCF / Share $-0.64

Trailing P/E —

Price / Book 108.9x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Aug 7, 2026.

26-Year Financial Trajectory

Quarterly

Metric Value Trend Year over Year Percentile

Net Income Profit after all expenses

$-2.54M

↑ +43.9% —

FCF / Share Free cash flow per share

$-0.64

↓ -78.8% —

info Signals below are graded against fixed quality thresholds, not peers — peer ranking needs more comparable companies.

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Return on Invested CapitalReturn on Invested Capital of -629.4% is weak on an absolute basis (target > 10%)
FCF / Net IncomeFCF / Net Income of 0.71x is caution on an absolute basis (target > 1x)

Health Breakdown

Cash Quality ↓

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 3 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
EPS Growth YoY (%)	28.1% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	70.3% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-831.2% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-1834.0% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	28.9% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-2119.1% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	31.9% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-20.5% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	11.8% Fair ↑ Fair Improving Year-over-year change in earnings per share Optimal: > 10%	-6.8% Weak → Weak Stable Year-over-year change in earnings per share Optimal: > 10%	-11.9% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	15.2% Good ↑ Good Improving Year-over-year change in earnings per share Optimal: > 10%	-24.4% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-100.0% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	48.1% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	—	-32.3% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	43.9% Excellent ↑ Excellent Improving Year-over-year change in net income	-96.4% Weak ↓ Weak Declining Year-over-year change in net income	-19.1% Weak ↓ Weak Declining Year-over-year change in net income	-19.1% Weak ↓ Weak Declining Year-over-year change in net income	-19.1% Weak ↓ Weak Declining Year-over-year change in net income	-3.2% Weak ↓ Weak Declining Year-over-year change in net income	10.5% Fair ↑ Fair Improving Year-over-year change in net income	10.5% Fair ↑ Fair Improving Year-over-year change in net income	10.5% Fair ↑ Fair Improving Year-over-year change in net income	-9.5% Weak ↑ Weak Improving Year-over-year change in net income	-26.4% Weak ↓ Weak Declining Year-over-year change in net income	-26.4% Weak ↑ Weak Improving Year-over-year change in net income	-26.4% Weak ↑ Weak Improving Year-over-year change in net income	-13.7% Weak ↑ Weak Improving Year-over-year change in net income	-449.5% Weak ↓ Weak Declining Year-over-year change in net income	54.7% Excellent ↑ Excellent Improving Year-over-year change in net income	-449.5% Weak ↓ Weak Declining Year-over-year change in net income	-317.6% Weak ↓ Weak Declining Year-over-year change in net income	-9.6% Weak Weak Year-over-year change in net income	-152.2% Weak Weak Year-over-year change in net income	—	—	—	—	—	—
FCF Growth YoY (%)	-78.8% Weak Weak Year-over-year change in free cash flow	—	—	—	23.2% Good Good Year-over-year change in free cash flow	—	—	—	21.1% Good Good Year-over-year change in free cash flow	—	—	—	-56.5% Weak Weak Year-over-year change in free cash flow	—	—	—	11.1% Fair Fair Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 2 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Effective Tax Rate (%) (%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	-0.2% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—	-1.6% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—
FCF / Net Income (x)	2.76x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	0.39x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.57x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.89x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.11x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	0.82x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	1.03x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	0.65x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	1.17x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	0.60x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	0.93x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.10x Fair ↓ Fair Declining Free cash flow relative to reported net income Optimal: > 1x	9.20x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	—	1.35x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	1.24x Good Good Free cash flow relative to reported net income Optimal: > 1x	-7.97x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Return on Invested Capital (%)	-136.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-204.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-45.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	210.4% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-129.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-83.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-41.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-52.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-33.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-27.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-21.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-14.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-16.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-13.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-10.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-10.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-8.1% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-7.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-7.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-53.1% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	58.5% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	255.4% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-238141.6% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	-18.2% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—	—
Return on Capital (%) (%)	—	-87.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-38.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-65.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-84.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-56.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-38.1% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-50.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-36.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-28.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-23.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-16.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-19.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-14.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-11.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-11.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-9.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-7.9% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	-36.8% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	-43.2% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—
Return on Common Equity (%) (%)	-203.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1458%)	-257.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1816%)	-98.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-756%)	270.9% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+1706%)	-161.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1179%)	-104.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-798%)	-63.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-523%)	-61.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-512%)	-40.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-371%)	-33.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-321%)	-27.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-285%)	-22.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-252%)	-20.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-234%)	-14.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-199%)	-12.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-181%)	-11.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-174%)	-10.1% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-167%)	-9.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-160%)	-1.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-111%)	-53.3% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-456%)	73.8% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+392%)	—	—	-18.2% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-221%)	—	—

⚖️ Is the balance sheet risky? 1 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Net Debt (USD)	$-1.50M	$-8.51M	$-5.83M	$-6.16M	$-3.89M	$-5.79M	$-7.38M	$-7.30M	$-9.74M	$-13.36M	$-15.96M	$-12.70M	$-6.81M	$-9.63M	$-6.72M	$-14.26M	$-33.22M	$-39.13M	—	$-16.99M	—	$-1.64M	—	$-13.80M	—	—

📊 What does each share earn? 5 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Basic EPS, GAAP (USD)	$-0.23	$-3.10	$-2.98	$-9.09	$-0.32	$-10.43	$-0.32	$-0.47	$-0.45	$-0.47	$-0.47	$-0.39	$-0.51	$-0.44	$-0.42	$-0.46	$-0.41	$-0.22	$-0.81	—	$-0.31	—	—	—	—	—
Free Cash Flow per Share (USD)	$-0.64	—	$-2.58	$-6.99	$-0.36	—	—	—	$-0.47	—	—	—	$-0.59	—	—	—	$-0.38	—	$-1.35	—	$-0.42	—	—	—	—	—
Book Value per Share (USD)	$0.01	$1.45	$2.81	$-0.10	$0.17	$9.20	$0.59	$0.72	$1.10	$1.44	$1.83	$2.22	$2.52	$2.93	$3.34	$3.68	$4.04	$4.35	$9.11	$7.50	$-0.43	$-0.12	—	—	—	—
Tangible Book Value per Share (USD)	$0.01	$1.45	$2.81	$-0.10	$0.17	$9.20	$0.59	$0.72	$1.10	$1.44	$1.83	$2.22	$2.52	$2.93	$3.34	$3.68	$4.04	$4.35	$9.11	$5.78	$-0.43	$-0.12	—	—	—	—
Basic Weighted Avg Shares (shares)	10.96M	—	997,038	574,923	14.10M	—	9.51M	8.54M	8.44M	—	8.40M	8.40M	8.40M	—	8.26M	8.26M	8.26M	—	4.18M	—	1.94M	—	—	—	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Working Capital (USD)	$1.25M	$3.15M	$4.20M	$-2.10M	$2.35M	$3.22M	$5.40M	$5.56M	$8.76M	$11.22M	$14.48M	$17.77M	$20.33M	$23.81M	$26.71M	$29.65M	$33.24M	$35.78M	—	$13.35M	—	$-283.50K	—	—	—	—
Total Equity (USD)	$1.25M	$3.15M	$4.61M	$-1.67M	$2.80M	$3.94M	$6.00M	$6.17M	$9.36M	$12.08M	$15.33M	$18.63M	$21.19M	$24.63M	$27.57M	$30.41M	$33.36M	$35.90M	$38.08M	$13.94M	$-829.68K	$-237.70K	$513.00	$16.18M	$2.69M	$3.21M

📋 What is driving earnings? 3 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Depreciation Expense (USD)	—	—	—	—	—	$0.00	—	—	$735.00	$320.00	—	—	$321.00	$321.00	—	—	$534.00	$535.00	$442.00	—	$213.00	$213.00	$-610.36K	—	—	—
Net Income, GAAP (USD)	$-2.54M	$-8.11M	$-4.53M	$-4.53M	$-4.53M	$-4.13M	$-3.81M	$-3.81M	$-3.81M	$-4.00M	$-4.25M	$-4.25M	$-4.25M	$-3.66M	$-3.37M	$-3.37M	$-3.37M	$-3.22M	$-612.42K	$-7.43M	$-612.42K	$-770.22K	$-558.58K	$-2.95M	—	—
Operating Cash Flow (USD)	$-7.01M	$-3.19M	$-2.57M	$-4.02M	$-5.05M	$-3.40M	—	—	$-3.94M	$-2.60M	—	—	$-4.96M	$-2.21M	—	—	$-3.12M	$-3.54M	$-5.63M	—	$-825.58K	$-957.03K	$4.45M	—	—	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 7 years · 26 quarters

Indaptus Therapeutics, Inc.

Analytical Summary

26-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Benchmarks unavailable

Compare INDP with peers